PacBio Announces Revio, a Revolutionary New Long Read Sequencing System Designed to Provide 15 Times More HiFi Data and Human Genomes at Scale for Under $1,000

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the Revio™ long-read...

Related Keywords

California ,United States ,Menlo ,Kansas ,Christian Henry ,Todd Friedman ,Gina Zastrow Hayes ,Pacific Biosciences ,Tomi Pastinen ,Corteva Agriscience ,Exchange Commission ,Research Use ,Securities Exchange ,Nasdaq ,Us Research Program ,California Inc ,Google Health ,Significant Advances ,New System Architecture Will Enable Revio ,Dramatically Increase Throughput ,Lower Cost While Leveraging ,Exceptional Accuracy ,Direct Methylation Detection ,Chief Executive Officer ,European Seed ,Genomic Answers For Kids ,Genomic Medicine Center ,Mercy Kansas ,Genomics Technology Manager ,Investor Relations ,Securities Exchange Act ,Securities Litigation Reform Act ,Pacific Biosciences Of California ,Nc ,Biotechnology ,Health Care Amp Hospitals ,Computer Amp Electronics ,New Products Amp Services ,